"multiple myeloma; dendritic cells; vaccine"@en . . "Moravcov\u00E1, Jana" . "Mich\u00E1lek, Jaroslav" . "P\u0159\u00EDprava protin\u00E1dorov\u00E9 vakc\u00EDny pro pacienty s mnoho\u010Detn\u00FDm myelomem na b\u00E1zi dendritick\u00FDch bun\u011Bk nalo\u017Een\u00FDch monoklon\u00E1ln\u00EDm imunoglobulinem" . . "Kov\u00E1\u0159ov\u00E1, Lucie" . "Penka, Miroslav" . . . . . . . . "0862-495X" . "H\u00E1jek, Roman" . "[86337D55304A]" . "Jel\u00EDnkov\u00E1, I." . "Vidl\u00E1kov\u00E1, Petra" . . "The preparation of anticancer vaccine for patients with multiple myeloma on the base of monoclonal immunoglobulin loaded dendritic cells"@en . "2" . . "Rycov\u00E1, Marcela" . "V \u010Dervnu 2006 byla na an\u0161em pracovi\u0161ti zah\u00E1jena klinick\u00E1 studie f\u00E1ze II zam\u011B\u0159en\u00E1 na pod\u00E1n\u00ED protin\u00E1dorov\u00E9 vakc\u00EDny pacient\u016F s mnoho\u010Detn\u00FDm myelomem. Vakc\u00EDna obsahovala dendritick\u00E9 bu\u0148ky pacienta nalo\u017Een\u00E9 autologn\u00EDm monoklon\u00E1ln\u00EDm imunoglobulinem produkovan\u00FDm myelomov\u00FDmi bu\u0148kami. Imunologick\u00E1 odpov\u011B\u010F byla zaznamen\u00E1ma u 3/4 pacient\u016F. Vakc\u00EDna byla velmi dob\u0159e sn\u00E1\u0161ena bez z\u00E1va\u017En\u00FDch vedlej\u0161\u00EDch \u00FA\u010Dink\u016F. Klinick\u00E1 studie pokra\u010Duje vakcinac\u00ED dal\u0161\u00EDch pacient\u016F s MM."@cs . . "O\u010Dadl\u00EDkov\u00E1, Darina" . "P\u0159\u00EDprava protin\u00E1dorov\u00E9 vakc\u00EDny pro pacienty s mnoho\u010Detn\u00FDm myelomem na b\u00E1zi dendritick\u00FDch bun\u011Bk nalo\u017Een\u00FDch monoklon\u00E1ln\u00EDm imunoglobulinem"@cs . . "CZ - \u010Cesk\u00E1 republika" . . . . . "V \u010Dervnu 2006 byla na an\u0161em pracovi\u0161ti zah\u00E1jena klinick\u00E1 studie f\u00E1ze II zam\u011B\u0159en\u00E1 na pod\u00E1n\u00ED protin\u00E1dorov\u00E9 vakc\u00EDny pacient\u016F s mnoho\u010Detn\u00FDm myelomem. Vakc\u00EDna obsahovala dendritick\u00E9 bu\u0148ky pacienta nalo\u017Een\u00E9 autologn\u00EDm monoklon\u00E1ln\u00EDm imunoglobulinem produkovan\u00FDm myelomov\u00FDmi bu\u0148kami. Imunologick\u00E1 odpov\u011B\u010F byla zaznamen\u00E1ma u 3/4 pacient\u016F. Vakc\u00EDna byla velmi dob\u0159e sn\u00E1\u0161ena bez z\u00E1va\u017En\u00FDch vedlej\u0161\u00EDch \u00FA\u010Dink\u016F. Klinick\u00E1 studie pokra\u010Duje vakcinac\u00ED dal\u0161\u00EDch pacient\u016F s MM." . "P\u0159\u00EDprava protin\u00E1dorov\u00E9 vakc\u00EDny pro pacienty s mnoho\u010Detn\u00FDm myelomem na b\u00E1zi dendritick\u00FDch bun\u011Bk nalo\u017Een\u00FDch monoklon\u00E1ln\u00EDm imunoglobulinem" . . "14110" . . "336197" . "Novotn\u00E1, H." . "RIV/00216224:14110/09:00035871!RIV10-MSM-14110___" . "P(LC06027)" . "Zahradov\u00E1, Lenka" . . . "On June 2006, phase II clinical trial focused on anticancer vaccination of multiple myeloma patients, was started. On September 2007, the immune and clinical response evaluation of first four patients was finished.The anticancer vaccine contained dendritic cells loaded with monoclonal immunoglobulin produced by myeloma cells. The immune response detected using ELISpot was observed in 3/4 patients. During the vaccination, no significant toxicities or negative side-effects were observed. The clinical trial is going on with vaccination other patients with multiple myeloma."@en . "22" . "P\u0159\u00EDprava protin\u00E1dorov\u00E9 vakc\u00EDny pro pacienty s mnoho\u010Detn\u00FDm myelomem na b\u00E1zi dendritick\u00FDch bun\u011Bk nalo\u017Een\u00FDch monoklon\u00E1ln\u00EDm imunoglobulinem"@cs . "Smejkalov\u00E1, Jana" . "Pour, Lud\u011Bk" . "Kyjovsk\u00E1, Drahom\u00EDra" . "6"^^ . . "12"^^ . "The preparation of anticancer vaccine for patients with multiple myeloma on the base of monoclonal immunoglobulin loaded dendritic cells"@en . . "14"^^ . . . "RIV/00216224:14110/09:00035871" . "Klinick\u00E1 onkologie" . .